News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Deals
Biogen Idec, Inc. (Massachusetts) To Spend Big On Acquisitions
February 23, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Biogen Idec Inc. (BIIB.O: Quote, Profile, Research) is ready, willing and able to spend billions of dollars to acquire new drugs to help fuel double digit returns over the next five years.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Biogen
MORE ON THIS TOPIC
Legal
Former Chinook Board Member Indicted for Insider Trading Related to $3.2B Novartis Buy
May 28, 2025
·
2 min read
·
Tristan Manalac
Pain
Lilly Follows Vertex Into Non-Opioid Pain With up to $1B SiteOne Buy
May 27, 2025
·
2 min read
·
Annalee Armstrong
Neuroscience
Epilepsy Biotech Nabs up to $570M in Deal With Italy’s Angelini Plus $140M Fundraising
May 27, 2025
·
1 min read
·
Annalee Armstrong
Mergers & acquisitions
Sanofi Buys Vigil for $470M Upfront, Reigniting a Battered Alzheimer’s Target
May 22, 2025
·
4 min read
·
Annalee Armstrong